CIK 0001528287 · <br>Emerging growth company
NeuroPace Inc
Sign in to watch- Ticker
- NPCE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 223550230
- Phone
- 6502372700
- Business address
- 455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA, 94043
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-22 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −237 | $10.94 | $3K | 90,689 |
| 2025-03-24 | Morrell Martha CHIEF MEDICAL OFFICER | Grant or award | +11,700 | 90,926 | ||
| 2025-03-24 | Morrell Martha CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +19,850 | 19,850 | ||
| 2025-03-21 | Geiger Uri Director | Grant or award | +987 | $12.02 | $12K | 10,896 |
| 2025-03-21 | LACOB JOSEPH Director | Grant or award | +935 | $12.02 | $11K | 11,000 |
| 2025-03-21 | Kumar Rakhi Director | Grant or award | +1,247 | $12.02 | $15K | 14,154 |
| 2025-03-21 | Fischer Frank M Director | Grant or award | +1,975 | $12.02 | $24K | 587,250 |
| 2025-03-10 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Grant or award | +11,700 | 136,595 | ||
| 2025-03-10 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Rt to Buy) | +19,850 | 19,850 | ||
| 2025-03-10 | Becker Joel CHIEF EXECUTIVE OFFICER | Grant or award | +58,500 | 106,464 | ||
| 2025-03-10 | Becker Joel CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Rt to Buy) | +99,200 | 99,200 | ||
| 2025-03-03 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,337 | $11.81 | $16K | 79,226 |
| 2025-03-03 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,337 | $11.81 | $16K | 124,895 |
| 2025-02-27 | Becker Joel CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −4,506 | $12.56 | $57K | 47,964 |
| 2025-02-27 | Kuhn Rebecca CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,430 | $12.56 | $18K | 126,232 |
| 2025-02-27 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −1,430 | $12.56 | $18K | 80,563 |
| 2025-02-21 | Morrell Martha CHIEF MEDICAL OFFICER | Sale | −78,334 | $13.72 | $1.1M | 81,993 |
| 2025-02-20 | Morrell Martha CHIEF MEDICAL OFFICER | Shares withheld for taxes | −3,405 | $14.23 | $48K | 43,670 |
| 2025-02-20 | Kuhn Rebecca Chief Financial Officer | Shares withheld for taxes | −3,405 | $14.23 | $48K | 127,662 |
| 2025-02-20 | KCK LTD. 10% owner | Sale | −5,270,845 | $9.40 | $49.5M | 0 |
Page 5 of 12 · 239 trades